Stocktoria
Humacyte, Inc. HUMA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-22
Humacyte, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 7,140,014 | $34.3M | 3.7% |
| AQR CAPITAL MANAGEMENT LLC | 1,924,691 | $1.2M | 1% |
| CITADEL ADVISORS LLC | 396,000 | $240,253 | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 177,536 | $107,711 | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 170,654 | $71,329 | 0.09% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.